Skip to main content
  • 47 Accesses

Abstract

In the treatment of respiratory disorders, the inhaled route is an effective method for delivering drugs directly to their required site of action in the lungs and seldom results in systemic side effects. Bronchodilator, corticosteroid, mucolytic and anti-allergic agents may be given as aerosols from a variety of inhalation devices. Pressurised metered dose inhalers are widely favoured since they are highly portable, unobtrusive and supposedly easy to use. They are most frequently used to deliver β2-adrenergic stimulating agents (bronchodilators) to the lungs, these aerosols being of particular value in the treatment of asthma and bronchitis (Paterson et al. 1979).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • British Pharmaceutical Codex (1977) The Pharmaceutical Press, London, pp 643–648

    Google Scholar 

  • Camner P, Philipson K (1978) Human alveolar deposition of 4 μm Teflon particles, Arch. Environ. Health 33: 181–185

    Google Scholar 

  • Camner P, Philipson K, Linnman L (1971) A simple method for nuclidic tagging of monodisperse fluorocarbon resin particles, Int. J. Appl. Radiât. Isot. 22: 731–734

    Article  Google Scholar 

  • Davies D S (1975) Pharmacokinetics of inhaled substances, Postgrad. Med. J. 51 (Supplement 7): 69–75

    Article  Google Scholar 

  • Fuchs N A, Sutugin A G (1966) in: Davies C N (ed) Aerosol Science, Academic Press, London, pl

    Google Scholar 

  • Gorman W G, Hall G D (1973) in: Swarbrick J (ed) Current Concepts in the Pharmaceutical Sciences: Dosage Form Design and Bioavailability, Lea and Febiger, Philadelphia, pp97–148

    Google Scholar 

  • Heyder J, Gebhart J, Stahlhofen W (1980) in: Willeke K (ed) Generation of Aerosols and Facilities for Exposure Experiments, Ann Arbor Science, Ann Arbor, pp65–103

    Google Scholar 

  • Hiller C, Mazumder M, Wilson D, Bone R (1978) Aerodynamic size distribution of metered-dose bronchodilator aerosols, Am. Rev. Respir. Dis. 118: 311–317

    Google Scholar 

  • Hiller F C, Mazumder M K, Smith G M, Bone R C (1980) Physical properties, hygroscopicity and estimated pulmonary retention of various therapeutic aerosols, Chest 77 (Supplement): 318–321

    Google Scholar 

  • May K R (1949) An improved spinning top homogeneous spray apparatus, J. Appl. Phys. 20: 932–938

    Article  Google Scholar 

  • Morén F (1978a) Drug deposition of pressurized inhalation aerosols I. Influence of actuator tube design, Int. J. Pharmaceutics 1: 205–212

    Article  Google Scholar 

  • Morén F (1978b) Drug deposition of pressurized inhalation aerosols II. Influence of vapour pressure and metered volume, Int. J. Pharmaceutics 1: 213–218

    Article  Google Scholar 

  • Morén F (1980) Studies on pressurized aerosols for oral inhalation, Abstracts of Uppsala Dissertations from the Faculty of Pharmacy, p33

    Google Scholar 

  • Nilsson H T, Simonsson B G, Ström B (1976) The fate of 3H-terbutaline sulphate administered to man as an aerosol, Eur. J. Clin. Pharmacol. 10: 1–7

    Article  Google Scholar 

  • Paterson J W, Conolly M E, Davies D S, Dollery C T (1968) Isoprenaline resistance and the use of pressurised aerosols in asthma, Lancet 2: 426–429

    Article  Google Scholar 

  • Paterson J W, Woolcock A J, Shenfield G M (1979) Bronchodilator drugs, Am. Rev. Respir. Dis. 120: 1149–1188

    Google Scholar 

  • Ruffin R E, Montgomery J M, Newhouse M T (1978) Site of beta-adrenergic receptors in the respiratory tract, Chest 74: 256–260

    Article  Google Scholar 

  • Stuart B O (1973) Deposition of inhaled aerosols, Arch. Intern. Med. 131: 60–73

    Article  Google Scholar 

  • Task Group on Lung Dynamics (1966) Deposition and retention models for internal dosimetry of the human respiratory tract, Health Phys. 12: 17 3–207

    Google Scholar 

  • Tothill P, Gait J M (1971) Quantitative profile scanning for the measurement of organ radioactivity, Phys. Med. Biol. 16: 625–634

    Article  Google Scholar 

  • Walker S R, Evans M E, Richards A J, Paterson J W (1972) The fate of (14C) disodium cromoglycate in man, J. Pharm. Pharmacol. 24: 525–531

    Article  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1982 C.G. Wilson, J.G. Hardy, M. Frier and S.S. Davis Croom Helm Ltd, 2-10 St John’ Road, London SW11

About this chapter

Cite this chapter

Newman, S.P., Pavia, D., Clarke, S.W. (1982). Therapeutic Aerosol Deposition. In: Wilson, C.G., Hardy, J.G., Frier, M., Davis, S.S. (eds) Radionuclide Imaging in Drug Research. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-9728-1_14

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-9728-1_14

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-011-9730-4

  • Online ISBN: 978-94-011-9728-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics